Quantum BioPharma Announces Unbuzzd Wellness Investor Webinar

Quantum BioPharma Ltd. announced that its licensee, Unbuzzd Wellness Inc., will host an Investor Webinar on October 30, 2025, as part of its Reg D 506(c) offering aiming to raise up to $5 million. The webinar will feature Unbuzzd's CEO John Duffy, Advisor Jason Sawyer, Medical Director Dr. Eric Hoskins, and Board Co-Chair Gerry David. They will discuss the investment opportunity for Unbuzzd, a scientifically-proven beverage that accelerates alcohol metabolism, restores mental clarity, and reduces hangover symptoms. Quantum BioPharma shareholders will not be diluted by this offering. Unbuzzd has completed a clinical trial showing significant benefits in reducing blood alcohol concentration, improving alertness, and alleviating hangover symptoms. The beverage is available in various pack formats and is marketed as a dietary supplement. Quantum BioPharma retains a 20.10% ownership in Unbuzzd Wellness Inc. and receives royalty payments from sales.